Trial intelligence / Profile preview

Propofol versus sevoflurane for optic nerve sheath diameter during laparoscopic sleeve gastrectomy

PACTR202605680434286Recruiting

Sponsor
Kafr El Sheikh Pharmaceutical Industries
Start
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of propofol and sevoflurane in obesity (2 arms), sponsored by Kafr El Sheikh Pharmaceutical Industries. Primary endpoint: Mean optic nerve sheath diameter. Started Oct 2025; status: recruiting.

02

Drugs

propofolsevoflurane
03

Conditions

obesity

Beyond the preview

Go deeper on PACTR202605680434286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202605680434286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call